Abstract:Following the publication of the above article, a concerned reader drew to the Editor's attention that the Transwell cell migration and invasion assay data featured in Fig. 2C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Reports , or were under consideration for publication at around the same time (some of which have been retracted). Furthermore, a number of overlapping data panels were identified comparing the migration and invasion assay data in Figs. 5C and 6C, such that data which were intended to show the results from differently performed experiments appeared to have been derived from the same original source(s). In view of the fact that certain of these data had already apparently been published previously, and given the lack of rigour on the part of the authors in assembling the data in Figs. 5 and 6, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 37: 501‐509, 2017; DOI: 10.3892/or.2016.5242]

[Retracted] MicroRNA‐19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway

[Retracted] MicroRNA‐320 targets mitogen‐activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer

[Retracted] microRNA‐206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α‐positive ovarian cancer cells

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

[Retracted] MicroRNA‐655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway

RETRACTION: MicroRNA-155 enhances the activation of Wnt/beta-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1 (Retraction of Vol 13, Pg 2221, 2016)

[Retracted] miRNA‐490‐3p promotes the metastatic progression of invasive ductal carcinoma

[Retracted] MicroRNA‐425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‐derived growth factor

[Retracted] Upregulation of microRNA‐181b inhibits CCL18‐induced breast cancer cell metastasis and invasion via the NF‐κB signaling pathway

[Retracted] LOC102724163 promotes breast cancer cell proliferation and invasion by stimulating MUC19 expression

[Retracted] lncRNA ROR promotes the progression of renal cell carcinoma through the miR‐206/VEGF axis

[Retracted] Downregulated microRNA‐140‐5p expression regulates apoptosis, migration and invasion of lung cancer cells by targeting zinc finger protein 800

[Retracted] MicroRNA‐140 represses glioma growth and metastasis by directly targeting ADAM9

[Retracted] miR‐148a‐3p suppresses epithelial ovarian cancer progression primarily by targeting c‐Met

[Retracted] Molecular mechanism of atractylon in the invasion and migration of hepatic cancer cells based on high‐throughput sequencing

MicroRNA‑744 Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells by Targeting SOX12.

[Retracted] MicroRNA‐362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1

[Retracted] MicroRNA‐30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9

[Retracted] miR‐218 functions as a tumor suppressor gene in cervical cancer

[Retracted] MicroRNA‐34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression

[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells